Supplements

SLU-PP-332

250 mcg per capsule

SLU-PP-332 is a finished dietary supplement delivering the synthetic pan-ERR (estrogen-related receptor) agonist SLU-PP-332 in oral capsule form — 250 mcg per capsule, 90 capsules per bottle.

Quantity

$55.99$69.9920% Off

Technical notes

Material Profile

Supplement Facts per 1 capsule: SLU-PP-332 250 mcg. Servings per container: 90. Daily value not established.

SLU-PP-332 has been studied in the literature as a pan-agonist of estrogen-related receptors ERRα, ERRβ, and ERRγ — nuclear receptors central to mitochondrial biogenesis, oxidative metabolism, and fatty-acid oxidation. Preclinical research has explored ERR activation as an exercise-mimetic pathway in metabolic and endurance models.

Suggested use: take 1 capsule daily with water or as recommended by a healthcare professional. Do not exceed the recommended dose. Consult a physician before use if pregnant, nursing, under 18, taking medication, or managing a medical condition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Literature

Research Citations

Curated entry points into the peer-reviewed record for this compound. Links open indexed searches at the U.S. National Library of Medicine so you can verify the current literature yourself rather than relying on a static citation list.

Compliance

SLU-PP-332 is supplied strictly as a laboratory reference material. It is not a drug, supplement, food, or cosmetic, and it is not for therapeutic or diagnostic use, human consumption, or veterinary use. Purchasers are responsible for handling the material in accordance with their institutional and jurisdictional requirements.

← Back to catalog

Customer reviews

Verified Feedback

Rating summary

Loading reviews…

Write a review

Your rating

All reviews are moderated before publication. Reviews describing human or veterinary use cannot be published.

    Shipping & Returns

    Delivery & Refund Policy

    Related Peptides

    Similar by category, dosage, or research focus.